Corporate Banner
Satellite Banner
RNAi
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

SMS-oncology Announces Changes to the Management Team

Published: Monday, February 04, 2013
Last Updated: Monday, February 04, 2013
Bookmark and Share
Specialized Medical Services-oncology BV announced its management team has been changed and expanded to five executive members.

Members are: Edwin Klumper (Chief Executive Officer, CEO), Philine van den Tol (Chief Operating Officer, COO), Eric van der Putten (Chief Business Development Officer, CBDO), Wouter Wijker (Managing Director Biometrics Unit), and Raymond Hoffmans (Director Consultancy).

The new CEO Edwin Klumper will succeed Eric van der Putten who will take on the position of CBDO. In his new role Eric will be responsible for driving new business opportunities and growing our client base. Edwin Klumper stated: "All credits go to Eric van der Putten who has been the driving force into building a fully GCP compliant CRO from scratch within five years that has resulted into ISO 9001:2008 certification in 2012. Our clients will benefit discussing their new cancer studies with Eric who brings to the table 30+ years of experience in running phase I and II cancer trials in close collaboration with the top tier of oncologists. His experience and operational insights will be of great value to our clients in achieving their objectives.”

Philine van den Tol has been promoted to the position of COO. With her no-nonsense and can-do attitude Philine motivates and leads by example the operational staff of SMS-oncology. She knows what it takes to run multiple multicenter cancer studies from her past experience as project manager for the Dutch Breast Cancer Trialists’ Group. The Management Team is completed by Raymond Hoffmans (Director Consultancy) and Wouter Wijker (Managing Director Biometrics Unit).

We thank Erik Leferink who has been leading in the foundation of SMS-oncology. Erik will hand over his business development responsibilities to Eric van der Putten. As a serial entrepreneur Erik will reallocate his time to grow new ventures that he has recently established. Erik will remain active as a shareholder of SMS-oncology.

“These changes reflect our steady growth and mark our next step”, said Edwin Klumper. “After 5 years of serving over 50 clients, building a highly motivated and oncology experienced staff, expanding our trial base across Europe, collaborating with top oncology centers, we are ready for our next step and ambition to become a European premier oncology CRO. It is a privilege to lead such a good team and serve our clients to jointly improve cancer treatment by developing new drugs that are desperately needed by so many patients".


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
RNAi Screening Trends
Understand current trends and learn which application areas are expected to gain in popularity over the next few years.
New Material Opens Possibilities for Super-Long-Acting Pills
A pH-responsive polymer gel could create swallow able devices, including capsules for ultra-long drug delivery.
New Tool For Investigating RNA Gone Awry
A new technology – called “Sticky-flares” – developed by nanomedicine experts at Northwestern University offers the first real-time method to track and observe the dynamics of RNA distribution as it is transported inside living cells.
Access Denied: Leukemia Thwarted by Cutting Off Link to Environmental Support
A new study reveals a protein’s critical – and previously unknown -- role in the development and progression of acute myeloid leukemia (AML), a fast-growing and extremely difficult-to-treat blood cancer.
New Weapon in the Fight Against Blood Cancer
This strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
TOPLESS Plants Provide Clues to Human Molecular Interactions
Scientists at Van Andel Research Institute have revealed an important molecular mechanism in plants that has significant similarities to certain signaling mechanisms in humans, which are closely linked to early embryonic development and to diseases such as cancer.
Toxin from Salmonid Fish has Potential to Treat Cancer
Researchers from the University of Freiburg decode molecular mechanism of fish pathogen.
Scientists Create CRISPR/Cas9 Knock-In Mutations in Human T Cells
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
Long-sought Discovery Fills in Missing Details of Cell 'Switchboard'
A biomedical breakthrough reveals never-before-seen details of the human body’s cellular switchboard that regulates sensory and hormonal responses.
Tracking Breast Cancer Before it Grows
A team of scientists led by University of Saskatchewan researcher Saroj Kumar is using cutting-edge Canadian Light Source techniques to screen and treat breast cancer at its earliest changes.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!